Pharmaceuticals, Biotechnology and Life Sciences
KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S.…
Cellectis grants additional rights to Servier to develop and commercialize all next generation gene-edited allogeneic CAR T-cell products targeting CD19,…
SAN FRANCISCO–(BUSINESS WIRE)–#DNA–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA…
LEXINGTON, Mass.–(BUSINESS WIRE)–Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that…
– First conditional approval of ZYNTEGLOTM (autologous CD34+ cells encoding βA-T87Q-globin gene) gene therapy for patients 12 years and older…
2019 Worldwide revenue of $230.8 million – an increase of 14.5% year over year 2019 U.S. revenue of $185.8 million…
– Audentes plans to invest over $100 million and create over 200 new jobs in Lee County SAN FRANCISCO &…
RED BANK, N.J.–(BUSINESS WIRE)–#cyberattacks–Sensato Cybersecurity Solutions (“Sensato”), has been awarded a group purchasing agreement for Cybersecurity with Premier. Effective December…
– First results from ocular injury program to treat damage from sulfur mustard gas – – Announces $1 million funding…
LONDON–(BUSINESS WIRE)–#Healthcare–The in situ hybridization (ISH) market is poised to grow by USD 346.61 million during 2020-2024, progressing at a…